A new study by a cross-disciplinary research ... to develop a vaccine which will make the immune system produce antibodies that bind effectively to the surface of the hepatitis C virus and thus ...

Those ethical costs are weighed against the fact that there are antiviral medications that can cure hepatitis C for 95% of patients. Rizza also noted there is an ongoing therapeutic vaccine trial.

Unfortunately, developing a hepatitis C vaccine has been difficult because ... vaccine development efforts—a cross-disciplinary research team at the University of Copenhagen made use of cyro ...

The hepatitis C virus (HCV), being an RNA virus ... 1) that can provide substantial enhancement to the efficacy of subunit vaccines. Clinical trials are currently underway to determine their ...

If none is present, they should get the vaccine again after treating hepatitis C. Previous research had shown that individuals with hepatitis C infection had a lower response to the hepatitis B ...

Dr. Kumar Nagarathinam, lead author of the study The study represents a significant milestone in vaccine research and could contribute to limiting the global spread of Hepatitis C in the long term.

The study represents a significant milestone in vaccine research and could contribute to limiting the global spread of Hepatitis C in the long term. Future research aims to further enhance the ...